MaxCyte Inc (MXCT NASDAQ) stock market data APIs
$0.8499
0.03(3.5%)
as of May 4, 2026
Try our APIs with
free plan!
MaxCyte Inc Financial Data Overview
Price chart is built with
Anychart
MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes cell therapeutics in the United States and internationally. The company's products consists of ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. It also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols. The company licenses and sells its instruments and technology; and sells its consumables to developers of cell therapies, as well as to pharmaceutical and biotechnology companies for use in drug discovery and development, and bio-manufacturing. MaxCyte, Inc. was incorporated in 1998 and is headquartered in Rockville, Maryland.
Prev. Close
0.8499
Open
0.8814
High
0.8868
Low
0.8455
52 wk Range
0.6434-2.86
Market Cap
91 910 K
Shares Outstanding
107 M
Revenue
33 026 K
EPS
-0.0566
Beta
1.566
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with MaxCyte Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get MaxCyte Inc data using free add-ons & libraries
Get MaxCyte Inc Fundamental Data
MaxCyte Inc Fundamental data includes:
- Net Revenue: 33 026 K
- EBITDA: -40 222 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-03-17
- EPS/Forecast: -0.078
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
MaxCyte Inc News
New
MaxCyte, Inc. Q4 2025 Earnings Call Summary
MaxCyte, Inc. Q4 2025 Earnings Call Summary - Moby Strategic Performance Attribution Performance was pressured by a 15% decline in activity from the company's largest customer due to manufacturing s...
MaxCyte outlines $30M–$32M 2026 revenue target as ExPERT DTx launch and SPL milestones drive outlook
Earnings Call Insights: MaxCyte (MXCT) Q4 2025 MANAGEMENT VIEW * Maher Masoud, President, CEO & Executive Director, highlighted that 2025 was a challenging year but also one of "meaningful progres...
MaxCyte (MXCT) Q4 2025 Earnings Call Transcript
Image source: The Motley Fool. DATE Tuesday, March 24, 2026 at 4:30 p.m. ET Call participants Chief Executive Officer — Maher Masoud Chief Financial Officer — Douglas J. Swirsky Chief Commerci...
MaxCyte Q4 Earnings Call Highlights
MaxCyte logo Key Points MaxCyte reported 2025 total revenue of $33.0 million (down 15% y/y) and core revenue of $29.6 million (down 9%), even as its instrument install base grew to 857 and the SeQur...
Get MaxCyte Inc fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
